Matthew R. Smith, MD, PhD - Combined Systemic Therapy to Combat Metastatic Hormone-Sensitive Prostate Cancer

Please visit answersincme.com/WGA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in oncology discusses the role of triplet therapy for patients with metastatic hormone-sensitive prostate cancer. Upon completion of this activity, participants should be better able to: Discuss recommended, evidence-based triplet therapies for patients with metastatic hormone-sensitive prostate cancer (mHSPC); Recognize patient and disease factors that can guide the selection of triplet treatment strategies for mHSPC; and Explain how to minimize adverse events for patients being treated with triplet therapy for mHSPC.